A detailed history of Walleye Capital LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 328,417 shares of CGEM stock, worth $4.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
328,417
Previous 92,869 253.63%
Holding current value
$4.42 Million
Previous $1.62 Million 239.53%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.03 - $20.86 $3.78 Million - $4.91 Million
235,548 Added 253.63%
328,417 $5.5 Million
Q2 2024

Aug 14, 2024

BUY
$15.63 - $29.35 $1.45 Million - $2.73 Million
92,869 New
92,869 $1.62 Million

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.